OMEGA HEALTHCARE INVESTORS INC Q1 FY2025 earnings call

• Taylor Pickett discussed first quarter financial results, noting adjusted funds from operations of $0.75 per share and FAD of $0.71 per share, reduced leverage to 3.7 times debt to EBITDA, and the revenue mix shift with private pay and other revenue increasing. Mentioned Genesis' rent situation in March and April.
• Bob Stephenson detailed financials, revenue growth driven by new investments, operator restructurings, etc., balance sheet strength with $368 million in cash and full credit facility capacity, and guidance assumptions including raised and narrowed 2025 AFFO guidance.
• Vikas Gupta talked about portfolio performance with trailing 12-month operator EBITDAR coverage improvement, new investments in 2025 totaling over $457 million, including U.K. and Jersey acquisitions, and favorable pipeline outlook.
• Megan Krull discussed federal court ruling on staffing mandate, budget resolutions, and Medicaid reform implications, including potential impacts on the industry.

In the first quarter of 2025, revenue was $277 million compared to $243 million in the first quarter of 2024. Net income was $112 million or $0.33 per common share versus $69 million or $0.27 per common share in Q1 2024. NAREIT FFO for Q1 was $184 million or $0.62 per share compared to $153 million or $0.60 per share in Q1 2024. Adjusted FFO was $221 million or $0.75 per share for the quarter, and FAD was $211 million or $0.71 per share. Over the last decade, the percentage of private pay and other revenue has increased from 8% to 39%, and this is expected to continue growing based on the current pipeline and tenant mix.

• Raised and narrowed 2025 adjusted FFO guidance to a range of $2.95 to $3.01 per share. Assumptions include no change in revenue related to operators on accrual basis, Maplewood's rent improvement, Genesis paying full rent and interest, debt maturities and extensions, and inclusion of new investments completed as of April 30. Projected quarterly G&A expense to run between $12 million to $14 million in 2025 and assume ability to repay $238 million of secured debt in November 2025 with equity.

• Genesis faced liquidity issues in March due to ABL lender borrowing base tightening and legacy liabilities, though paid full rent in April and remains current on interest obligations. The $118 million term loan is fully secured by Genesis ancillary businesses.
• Medicaid reform risks with potential spending cuts and provider tax changes, impact on the portfolio varying by state and difficult to predict at this time.

Q: Jonathan Hughes of Raymond James asked about Genesis' corporate capital structure, accounting basis, and U.K. portfolio acquisition.

A: Taylor Pickett stated Genesis has a weak balance, is on cash basis accounting, and Vikas Gupta detailed the U.K. acquisition as an example of a strong platform, with six operators involved and assets in Scotland and Jersey fitting well in operators' geographies.

Q: Seth Berge from Citibank inquired about immigration impact on labor and Genesis' operating fundamentals.

A: Megan Krull said no immigration impact seen yet, and Bob Stephenson noted Genesis' coverage metric is above 1.5x and directionally improved.

Q: Juan Sanabria from BMO Capital Markets asked about Genesis loan PIK interest, U.S. fee simple acquisitions, and HUD lending.

A: Bob Stephenson mentioned $2.4 million uptick in loan book, Taylor Pickett said not part of Welltower's bid process for a large SNF deal, and Taylor Pickett noted no change heard on HUD lending front.

Q: Emily Meckler from Green Street asked about PACS portfolio re-tenancy and transaction market underwriting criteria.

A: Vikas Gupta said PACS portfolio has strong coverage and no exit discussions, and Vikas Gupta stated underwriting criteria unchanged despite Medicaid changes.

Q: Omotayo Okusanya from Deutsche Bank asked about Genesis' ABL lender impact and term loan LTV.

A: Taylor Pickett said Genesis issue is specific, and Taylor Pickett guessed substantially over collateralized on the $118 million term loan.

Q: Nick Yulico from Scotiabank inquired about Genesis lease escalator, straight line rent, and provider tax.

A: Vikas Gupta said no change to lease rent or escalator, Taylor Pickett mentioned straight line rent benefit, and Megan Krull discussed provider tax risks and state variations.